Literature DB >> 17558486

The c-Jun N-terminal kinase JNK participates in cytokine- and isolation stress-induced rat pancreatic islet apoptosis.

S Abdelli1, A Abderrahmani, B J Hering, J S Beckmann, C Bonny.   

Abstract

AIMS/HYPOTHESIS: The protocols used for the preparation of human pancreatic islets immediately induce a sustained and massive activation of the c-Jun-N-terminal kinase (JNK). JNK, which participates in apoptosis of insulin-secreting cells, is activated by mechanical stresses, as well as by exposure to pro-inflammatory cytokines. Here, we investigated whether the delivery of a protease-resistant JNK inhibitory peptide (D-JNKI) through a protein transduction system during pancreatic digestion might impair JNK signalling throughout the transplantation procedure.
METHODS: Rat pancreases were treated with D-JNKI through the pancreatic duct and cells then isolated by enzymatic digestion. Protein extracts were prepared to determine JNK activity by kinase assays and total RNA was extracted to measure gene expressions by a Light-Cycler technique. Cell apoptosis rate was determined by terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay and by scoring cells displaying pycnotic nuclei.
RESULTS: Our data establish that the peptide transduction system used here efficiently transfects islets, allowing for stable in vivo (up to 2 days) transfection of human islets transplanted under the kidney capsule. Further, D-JNKI decreases intracellular JNK signalling during isolation and following cytokine exposure in both human and rat islets, as measured by kinase assays and reduced c-fos expression; D-JNKI also confers protection against apoptosis induced during the rat islet preparation and subsequent to IL-1beta exposure. CONCLUSIONS/
INTERPRETATION: JNK signalling participates in islet isolation- and IL-1beta-induced apoptosis in rat islets. Furthermore, the system we used might be more generally applicable for the persistent blockage (several days) of pro-apoptotic pathways in the transplanted islets; this days-long protection might potentially be an absolute prerequisite to help transplanted islets better survive the first wave of the non-specific inflammatory attack.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558486     DOI: 10.1007/s00125-007-0704-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

Review 1.  beta-cell apoptosis: stimuli and signaling.

Authors:  T Mandrup-Poulsen
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

2.  Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

Authors:  Kristina I Rother; David M Harlan
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 3.  Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.

Authors:  Neal R Barshes; Samuel Wyllie; John A Goss
Journal:  J Leukoc Biol       Date:  2005-02-22       Impact factor: 4.962

4.  Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans.

Authors:  T Mandrup-Poulsen; K Bendtzen; J Nerup; C A Dinarello; M Svenson; J H Nielsen
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

5.  Production of TNF alpha, IL-1, IL-6 and nitric oxide by isolated human islets.

Authors:  E Vara; J Arias-Díaz; C García; J Hernández; C García-Carreras; A Cuadrado; J L Balibrea
Journal:  Transplant Proc       Date:  1995-12       Impact factor: 1.066

6.  Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.

Authors:  C Bonny; A Oberson; S Negri; C Sauser; D F Schorderet
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

7.  c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor.

Authors:  Juan-Jose Ventura; Norman J Kennedy; Jennifer A Lamb; Richard A Flavell; Roger J Davis
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.

Authors:  E A Ryan; J R Lakey; R V Rajotte; G S Korbutt; T Kin; S Imes; A Rabinovitch; J F Elliott; D Bigam; N M Kneteman; G L Warnock; I Larsen; A M Shapiro
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

9.  Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets.

Authors:  Reid Aikin; Dusica Maysinger; Lawrence Rosenberg
Journal:  Endocrinology       Date:  2004-07-08       Impact factor: 4.736

10.  Molecular mechanisms of neuronal cell death: implications for nuclear factors responding to cAMP and phorbol esters.

Authors:  Sheela Vyas; Nicole Faucon Biguet; Patrick P Michel; Lucia Monaco; Nicholas S Foulkes; Gerard I Evan; Paolo Sassone-Corsi; Yves Agid
Journal:  Mol Cell Neurosci       Date:  2002-09       Impact factor: 4.314

View more
  24 in total

1.  ATF2 interacts with beta-cell-enriched transcription factors, MafA, Pdx1, and beta2, and activates insulin gene transcription.

Authors:  Song-iee Han; Kunio Yasuda; Kohsuke Kataoka
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

2.  25 YEARS OF THE RICORDI AUTOMATED METHOD FOR ISLET ISOLATION.

Authors:  Lorenzo Piemonti; Antonello Pileggi
Journal:  CellR4 Repair Replace Regen Reprogram       Date:  2013

Review 3.  Role of Wnt signaling pathways in type 2 diabetes mellitus.

Authors:  Jing Chen; Chong Ning; Jingjing Mu; Dongnan Li; Yan Ma; Xianjun Meng
Journal:  Mol Cell Biochem       Date:  2021-02-10       Impact factor: 3.396

4.  An optimized protocol for purification of functional islets of Langerhans.

Authors:  Youakim Saliba; Jules-Joel Bakhos; Tarek Itani; Nassim Farès
Journal:  Lab Invest       Date:  2016-11-28       Impact factor: 5.662

5.  Prolactin supplementation to culture medium improves beta-cell survival.

Authors:  Toshiyuki Yamamoto; Atsuyoshi Mita; Camillo Ricordi; Shari Messinger; Atsushi Miki; Yasunaru Sakuma; Francesca Timoneri; Scott Barker; Alessia Fornoni; R Damaris Molano; Luca Inverardi; Antonello Pileggi; Hirohito Ichii
Journal:  Transplantation       Date:  2010-06-15       Impact factor: 4.939

6.  An Isogenic Human ESC Platform for Functional Evaluation of Genome-wide-Association-Study-Identified Diabetes Genes and Drug Discovery.

Authors:  Hui Zeng; Min Guo; Ting Zhou; Lei Tan; Chi Nok Chong; Tuo Zhang; Xue Dong; Jenny Zhaoying Xiang; Albert S Yu; Lixia Yue; Qibin Qi; Todd Evans; Johannes Graumann; Shuibing Chen
Journal:  Cell Stem Cell       Date:  2016-08-11       Impact factor: 24.633

7.  Baculoviral inhibitors of apoptosis repeat containing (BIRC) proteins fine-tune TNF-induced nuclear factor κB and c-Jun N-terminal kinase signalling in mouse pancreatic beta cells.

Authors:  B M Tan; N W Zammit; A O Yam; R Slattery; S N Walters; E Malle; S T Grey
Journal:  Diabetologia       Date:  2012-12-20       Impact factor: 10.122

8.  c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.

Authors:  J L Varona-Santos; A Pileggi; R D Molano; N Y Sanabria; A Ijaz; M Atsushi; H Ichii; R L Pastori; L Inverardi; C Ricordi; A Fornoni
Journal:  Diabetologia       Date:  2008-10-14       Impact factor: 10.122

9.  JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis.

Authors:  S Abdelli; J Puyal; C Bielmann; V Buchillier; A Abderrahmani; P G H Clarke; J S Beckmann; C Bonny
Journal:  Diabetologia       Date:  2009-07-16       Impact factor: 10.122

Review 10.  Insulin resistance: an emerging link in Alzheimer's disease.

Authors:  Bikash Medhi; Mrinmoy Chakrabarty
Journal:  Neurol Sci       Date:  2013-05-14       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.